C07F7/1804

Aspartic acid ester-functional polysiloxanes, their preparation and use thereof

The present invention relates to aspartic acid ester-functional polysiloxanes, their use in the manufacture of curable compositions using polyisocyanate crosslinkers, in particular, in the manufacture of coating compositions, cured compositions obtained from said curable compositions and articles comprising the cured compositions.

Silane mixtures and process for preparing same

The invention relates to silane mixtures comprising a silane of the formula I
(R.sup.1).sub.y(R.sup.2).sub.3-ySi—R.sup.3—(S—R.sup.4).sub.n—S.sub.x—R.sup.5  (I)
and a silane of the formula II
(R.sup.1).sub.y(R.sup.2).sub.3-ySi—R.sup.3—Si(R.sup.1).sub.y(R.sup.2).sub.3-y  (II)
where the molar ratio of silane of the formula I to silane of the formula II is 15:85-90:10. The silane mixture according to the invention can be prepared by mixing the silanes of the formula I and silanes of the formula II.

Alkyldiphenylmethane protective agent

Provided is an alkyldiphenylmethane protective agent, which can prevent solidification or insolubilization of a compound by protecting a functional group of the compound to achieve easy separation and purification after a reaction. An alkyldiphenylmethane compound represented by general formula (1): ##STR00001## wherein Y represents —OR.sup.19 (wherein R.sup.19 represents a hydrogen atom or an active ester-type protecting group), —NHR.sup.20 (wherein R.sup.20 represents a hydrogen atom, a C.sub.1-6 linear or branched alkyl group, or an aralkyl group), isocyanate group, an azide group, or a halogen atom, Z represents a C.sub.1-4 linear or branched alkyl group, an alkenyl group, or a cycloalkyl group, at least one of R.sup.1 to R.sup.10 represents a group represented by formula (2):
—O—R.sup.11—X-A  (2) and the others each independently represent a hydrogen atom, a halogen atom, a C.sub.1-4 alkyl group, or a C.sub.1-4 alkoxy group; R.sup.11 represents a C.sub.1-16 linear or branched alkylene group; X represents O or CONR.sup.21 (wherein R.sup.21 represents a hydrogen atom or a C.sub.1-4 alkyl group); and A represents, for example, a group represented by formula (3): ##STR00002## wherein R.sup.12, R.sup.13, and R.sup.14 may be the same or different and each independently represent a C.sub.1-6 linear or branched alkyl group or an optionally substituted aryl group; R.sup.15 represents a single bond or a C.sub.1-3 linear or branched alkylene group; and R.sup.16, R.sup.17, and R.sup.18 each independently represent a C.sub.1-3 linear or branched alkylene group.

CARBONATE CONTAINING LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

The disclosure features novel lipids and compositions involving the same. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

Pyrimidine derivative compound, pharmaceutically acceptable salt thereof, preparation process thereof, and pharmaceutical composition using the same
11535627 · 2022-12-27 · ·

The present invention is related to a novel pyrimidine derivative compound or a pharmaceutically acceptable salt thereof, a process for preparing the same, and a pharmaceutical composition using the same.

Arylaminosilane compound, propylene polymerization catalyst and preparation thereof

The present disclosure discloses an arylaminosilane compound, a propylene polymerization catalyst and preparation thereof. The arylaminosilane compound has a structure of ##STR00001##
wherein R.sub.1 is a C.sub.1-C.sub.8 alkyl group or a C.sub.1-C.sub.8 silanyl group; R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are each independently H or a C.sub.1-C.sub.12 alkyl group; R.sub.7, R.sub.8 and R.sub.9 are each independently a C.sub.1-C.sub.8 alkyl group or a C.sub.1-C.sub.8 alkoxy group. When the arylaminosilane compound is used as an external electron donor of a propylene polymerization catalyst in propylene polymerization reaction, the catalyst has good hydrogen response.

RUBBER COMPOSITION AND TIRE
20220403057 · 2022-12-22 · ·

Provided is a rubber composition that realizes excellent low heat generating properties while maintaining good steering stability when applied to a tire. The rubber composition of the present disclosure contains a rubber component containing a copolymer having a conjugated diene unit and an aromatic vinyl unit, and a filler, where the copolymer is a modified copolymer having a content of the aromatic vinyl unit of less than 10 mass % and modified with a modifier containing a compound represented by the formula (1).

##STR00001##

Silane compound including fluorine-containing (poly)ether group, composition including the same, film formed from the composition, display device comprising the film, and article comprising the composition

Disclosed are a composition comprising a silane compound having a fluorine-containing (poly)ether group represented by Formula 1, a film formed from the composition, a display device including the film, and an article including a coating product of the composition:
Rf-(L.sup.1).sub.p1(L).sub.a-C(═O)NR-(L.sup.2).sub.p2-Si(R.sub.1)(R.sub.2)(R.sub.3)   Formula 1 wherein in Formula 1, R is -(L.sup.3).sub.p3-Si(R.sub.4)(R.sub.5)(R.sub.6), L is —CH.sub.2— or —CH.sub.2—O—CH.sub.2—, Rf is a fluorine-containing (poly)ether group, and L.sup.1 to L.sup.3, p1 to p3, and R.sub.1 to R.sub.6 are the same as defined in the detailed description.

SUBSTITUTED INDAZOLES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAID NEW SUBSTITUTED INDAZOLES, AND USE OF SAID NEW SUBSTITUTED INDAZOLES TO PRODUCE DRUGS

The present application relates to novel substituted indazoles, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of endometriosis and endometriosis-associated pain and other endometriosis-associated symptoms such as dysmenorrhoea, dyspareunia, dysuria and dyschezia, of lymphoma, rheumatoid arthritis, spondyloarthritis (especially psoriatic spondyloarthritis and Bekhterev's disease), lupus erythematosus, multiple sclerosis, macular degeneration, COPD, gout, fatty liver disorders, insulin resistance, neoplastic disorders and psoriasis.

COMPOUND AND METHOD FOR PRODUCING COMPOUND

The present invention provides an intermediate compound for easily producing a compound having an azaperylene skeleton. Another object of the present invention is to provide a method for easily producing a compound having an azaperylene skeleton.

The compound of the present invention is a compound represented by Formula (I), or a compound represented by Formula (II).

##STR00001##